![Claire S. Padgett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Claire S.
Padgett formerly worked at Conforma Therapeutics Corp., as Executive Director-Clinical Operations, Oncolytics Biotech, Inc., as Vice President-Clinical Operations, Cylene Pharmaceuticals, Inc., as Vice President-Clinical Operations, Mirati Therapeutics, Inc., as Senior Vice President-Clinical Operations from 2017 to 2018, Regulus Therapeutics, Inc., as Senior Vice President-Clinical Operations from 2022 to 2025, and Mast Therapeutics, Inc., as Vice President-Clinical Operations from 2012 to 2018.
Dr. Padgett received her undergraduate degree from Rutgers State University of New Jersey, graduate degree and Masters Business Admin degree from Seton Hall University, and doctorate degree from Capella University LLC.
Tidigare kända positioner av Claire S. Padgett
| Företag | Position | Slut |
|---|---|---|
| REGULUS THERAPEUTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-12-01 |
| MIRATI THERAPEUTICS | Företagsledare/Principal | 2018-10-01 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Teknisk/Vetenskaplig/F&U Direktör | 2018-10-01 |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs | Verksamhetschef | 2010-09-28 |
| ONCOLYTICS BIOTECH INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Claire S. Padgetts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
37
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
 Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capella University LLC
 Capella University LLC Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
